| Date | Target |
Transaction Type Value: $mlns |
Acquirer | Seller | ||
|---|---|---|---|---|---|---|
| 2022-06-07 |
ImmunOs Therapeutics
Life Science Schlieren, Switzerland www.immunostherapeutics.com ImmunOs Therapeutics is a preclinical stage biotech company which develops a proprietary target discovery platform allowing to discover novel molecules inspired by HLA molecules and physiological immunosuppressive molecules. ImmunOs Therapeutics was founded in 2014 and is based in Schlieren, Switzerland. |
Venture |
GIMV
|
- | ||
| Deal Article Deal Link | ||||||
| 2022-02-09 |
Scandit
Software Zurich, Switzerland www.scandit.com Scandit engages in smart data capture giving superpowers to workers, customers, and businesses with unmatched speed, accuracy, and intelligence. Scandit Smart Data Capture platform enables smart devices, such as smartphones, drones, digital eyewear, and robots to capture data from barcodes, text, IDs, and objects to automate and provide insights for end-to-end processes. Scandit was founded in 2009 and is based in Zurich, Switzerland. |
Venture |
Warburg Pincus
|
- | ||
| Deal Article Deal Link | ||||||
| 2021-11-16 |
Anjarium Biosciences
Life Science Schlieren, Switzerland www.anjarium.com Anjarium Biosciences is a biotech company focused on creating and delivering a new class of non-viral gene therapies. Anjarium Biosciences was founded in 2017 and is based in Schlieren, Switzerland. |
Venture |
GIMV
|
- | ||
| Deal Article Deal Link | ||||||
| 2020-12-01 |
Noema
Life Science Basel, Switzerland www.noemapharma.com Noema is developing therapies to restore functioning in patients with orphan conditions of the brain and nervous system. Noema was founded in 2019 and is based in Basel, Switzerland. |
Venture |
Polaris Partners
Gilde Healthcare
|
- | ||
| Deal Article Deal Link | ||||||
| 2020-09-16 |
Polyneuron
Life Science Basel, Switzerland www.polyneuron.com Polyneuron has a unique approach in using antigen-specific polymers to target and eliminate the pathological antibodies causing serious autoimmune diseases with a high unmet medical need. Polyneuron was founded in 2014 and is based in Basel, Switzerland. |
Venture |
HBM Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2020-04-22 |
FoRx Therapeutics
Life Science Basel, Switzerland www.forxtherapeutics.com FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways. FoRx Therapeutics was founded in 2019 and is based in Basel, Switzerland. |
Venture |
EQT Life Sciences
Pfizer
|
- | ||
| Deal Article Deal Link | ||||||
| 2019-02-01 |
Arvelle Therapeutics
Life Science Zug, Switzerland www.arvelletx.com Arvelle Therapeutics is an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders. Arvelle Therapeutics was founded in 2019 and is based in Zug, Switzerland. |
Venture |
Andera Partners
Eight Roads
|
- | ||
| 2017-03-01 |
Swiss QualiQuest
Internet Software and Services Bern, Switzerland www.swissqualiquest.ch Swiss QualiQuest is an online rating portal for customer ratings for SMEs from simple systems for smaller companies to comprehensive solutions for large companies, organizations, or entire industries. Swiss QualiQuest was founded in 2015 and is based in Bern, Switzerland. |
Venture |
Wineus Capital
|
- | ||
| 2016-10-12 |
ObsEva
Life Science Geneva, Switzerland www.obseva.com ObsEva is a biopharmaceutical company developing novel therapeutics in women's health for the treatment of symptoms associated with endometriosis and uterine fibroids. ObsEva was founded in 2012 and is headquartered in Geneva, Switzerland. |
Venture |
HBM Partners
|
- | ||
| Deal Article Deal Link | ||||||
| 2016-05-17 |
Nouscom
Life Science Basel, Switzerland www.nouscom.com Nouscom is developing next-generation neo-epitope vaccines and oncolytic viruses. Nouscom was founded in 2015 and is based in Basel, Switzerland. |
Venture |
EQT Life Sciences
|
- | ||
| Deal Article Deal Link | ||||||
| 2016-04-13 |
Nexthink
Internet Software and Services Lausanne, Switzerland www.nexthink.com Nexthink provides a cloud-based software platform that enables IT departments to monitor, analyse, and improve the digital employee experience by collecting real-time data on devices, applications, networks, and employee feedback, then triggering automated remediation. The Company was founded in 2004 and is headquartered in Lausanne, Switzerland. |
Venture |
Highland Europe
|
- | ||
| 2013-09-12 |
Covagen AG
Life Science Zurich, Switzerland www.covagen.com Covagen is a clinical stage company that develops bispecific FynomAbs by fusing its human Fynomer® binding proteins to antibodies, resulting in therapeutics with novel modes of action and enhanced efficacy. Our current pipeline is focussed on the treatment of inflammatory diseases and cancer. The ability to fuse Fynomers to multiple sites on an antibody allows Covagen to create FynomAbs with tailored architectures to maximize efficacy. |
Venture |
GIMV
|
- | ||
| 2013-07-09 |
OncoEthix SA
Life Science Lausanne, Switzerland OncoEthix is a privately held biotechnology company aiming to develop a small portfolio of oncology drug candidates. The Company’s lead product, OTX015, is an investigational orally administered synthetic small molecule targeted to BET bromodomain proteins 2/3/4. OTX015 was in-licensed from Mitsubishi Tanabe Pharma Corporation in March 2012 following completion of Phase I clinical studies in healthy volunteers. |
Venture |
Edmond de Rothschild Private Equity
|
- | ||
| 2011-07-05 |
MyoPowers Medical Technologies SA
Medical Products Lausanne, Switzerland www.myopowers.com MyoPowers Medical Technologies SA is a medical device company focused on developing battery-powered implantable medical devices for the treatment of severe stress urinary incontinence in males and females. MyoPowers Medical Technologies was formed in 2004 and is based in Lausanne, Switzerland. |
Venture |
Truffle Capital
|
- | ||
| Deal Article Deal Link | ||||||
| 2011-03-24 |
Genkyotex SA
Life Science Geneva, Switzerland www.genkyotex.com Genkyotex SA is a specialty pharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs. Genkyotex was founded in 2006 and is based in Geneva, Switzerland. |
Venture |
Edmond de Rothschild Private Equity
|
- | ||
| 2009-12-15 |
Molecular Partners
Life Science Schlieren, Switzerland www.molecularpartners.com Molecular Partners is a clinical-stage biotech company developing DARP in therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. Molecular Partners was founded in 2004 and is headquartered in Schlieren, Switzerland. |
Venture |
EW Healthcare Partners
|
- | ||
| Avg |
$0.0
0.0x EBITDA 0.0x REVENUE |
|||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr was built to simplify the process of tracking who’s buying, selling, and what deals are happening across the private markets.
Behind every transaction is an opportunity, and Mergr gives professionals access to thousands of M&A deals, along with the investors, buyers, and sellers behind them.
The platform is powerful but easy to use — so you can quickly surface relevant transactions and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.
